Related Experiment Video
Updated: Sep 10, 2025
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
Heterogeneity in Normal-Appearing Lung Tissue is Similar Between COPD and Smokers, and Predicts Morbidity and
Joyce John1, Kelly S Burrowes1, Surya P Bhatt2
1Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand (J.J., K.S.B., H.K., T.J., M.H.T.).
Background:
Studies have identified important associations between computed tomography (CT) features of the normal-appearing lung tissue and patient outcomes, however, the heterogeneity of normal-appearing tissue has not previously been considered in chronic obstructive pulmonary disease (COPD).
Methods:
We aimed to quantify heterogeneity in normal-appearing lung tissue on inspiratory CT imaging and its relationship with lung function and clinical outcomes. We analysed data from 520 participants enroled in the COPDGene study, including never-smokers, current and former smokers without airflow obstruction, and COPD (GOLD1-4). Quadtree decomposition was used to derive spatially-connected heterogeneity metrics for medium (-900 to -750 HU) and low (< -900 HU) density tissues, and for all tissues combined. Medium density included tissue typically classified as normal-appearing by HU thresholding. Associations between heterogeneity, lung function, and respiratory morbidity were tested using multivariable regression.
Results:
Heterogeneity in medium-density tissue was similar between current and former smokers without airflow obstruction and COPD (0.15±0.05 cf. 0.16±0.06, p=0.11), and was significantly higher than in never-smokers (0.10±0.03, p<0.001). After adjusting for emphysema, age, sex, race, smoking status, and BMI, heterogeneity was independently associated with FEV1 % predicted, St. George's Respiratory Questionnaire score, modified Medical Research Council dyspnoea score, six-minute walk distance, and greater FEV1 decline at follow-up.
Conclusion:
Heterogeneity of normal-appearing lung tissue is associated with respiratory morbidity and disease progression in COPD. This highlights the importance of detecting subtle early changes in tissue architecture in current and former smokers at risk for and with COPD.
Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: